Workplace reform with changing management through the user participation workshop : the case study of Seiyo City Office / Ikumi Egawa

The research explains about workplace reform, aimed at improving productivity of General Affairs and Policy Planning department of Seiyo officeby changing management through the user participation workshop at 4th floor of Seiyo city office and on the changes of workplace reform. The purpose of this research is to find the changes that are worker's behaviour and worker’s awareness of workplace through workplace reform. The researchers surveyed changes, worker's behaviour and worker's awareness of workplace using workplace reform at 4th floor of Seiyo office as case study. In workplace reform, in order to create a place where new work style can be practiced, the researchers conducted the user participation workshops with workers a total of 6 times. Through the workshops, concept of work style and plan of renovation were proposed. In addition, the researchers did a survey using two methods which were a set of questionnaire and 3 observationsthat is before the workplace renovation, 3 months after the renovation, and 1 year and 3 months after the renovation. The findings obtained from the questionnaire in the first three months after the renovation showed that the opinions of the workers were divided between pros and cons against workplace reform. However, the survey of 1 year and three months after the renovation showed that almost all workers are satisfied with the new environment. In addition, the researchers found that a positive correlation exist between participation rate of workshops and the satisfaction level. The findings suggest the worth of workshops for workplace reform. In the Observation Survey, the workers needed to select a place freely where they can work comfortably after the workplace reform. For example, they chose to work in refresh space. In addition, the findings from the survey showed that the floor became livelier when the participation rate increses at that workplace. Additionally, the participants became more conscious of the work style such as features of work style, after workplace renovation; they are able to clearly differentiate between short intermittent works separated by conversation and phone and personal work on concentration

The Type Ic Hypernova SN 2002ap

Photometric and spectroscopic data of the energetic Type Ic supernova (SN) 2002ap are presented, and the properties of the SN are investigated through models of its spectral evolution and its light curve. The SN is spectroscopically similar to the "hypernova" SN 1997ef. However, its kinetic energy [$\sim (4-10) \times 10^{51}$ erg] and the mass ejected (2.5-5 $M_{\odot}$) are smaller, resulting in a faster-evolving light curve. The SN synthesized $\sim 0.07 M_{\odot}$ of $^{56}$Ni, and its peak luminosity was similar to that of normal SNe. Brightness alone should not be used to define a hypernova, whose defining character, namely very broad spectral features, is the result of a high kinetic energy. The likely main-sequence mass of the progenitor star was 20-25 $M_{\odot}$, which is also lower than that of both hypernovae SNe 1997ef and 1998bw. SN 2002ap appears to lie at the low-energy and low-mass end of the hypernova sequence as it is known so far. Observations of the nebular spectrum, which is expected to dominate by summer 2002, are necessary to confirm these values.Comment: 10 pages, 4 figures, accepted for publication in ApJL, 30 April 2002 (minor changes to match the accepted version, with figures being colored

Neurological outcomes associated with prehospital advanced airway management in patients with out-of-hospital cardiac arrest due to foreign body airway obstruction

Objectives: Several studies have examined the association between advanced airway management (AAM) and survival for arrest that is non-shockable, noncardiac in origin, or due to suffocation; however, the efficacy of prehospital AAM compared with no AAM following foreign body removal by emergency medical services (EMS) has not been examined. We aimed to compare neurological outcomes in patients after out-of-hospital cardiac arrest (OHCA) due to foreign body airway obstruction (FBAO) managed with and without AAM after foreign body removal. Methods: This retrospective observational cohort study used all emergency transportation data of Japan and the All-Japan Utstein Registry. We included patients with OHCA aged ≥18 years undergoing resuscitation and removal of airway foreign bodies by EMS from January 2015 to December 2017. The exposure of interest was prehospital AAM by EMS after foreign body removal, and the primary outcome was a favorable neurological outcome at hospital discharge (i.e., a cerebral performance category of 1–2). Results: Overall, 329,098 adults had OHCAs and 23,060 had foreign bodies removed from their airways; 3681 adult patients met our eligibility criteria and were divided as: AAM (2045) and non-AAM (1636) groups. Propensity score matching resulted in 1210 matched pairs with balanced baseline characteristics between the groups. The rate of favorable neurological outcome was significantly lower in the AAM group than in the non-AAM group (OR 0.34, 95% CI 0.19–0.62). However, survival was not significantly different between the two groups (OR 1.08, 95% CI 0.84–1.37). Conclusions: We have not demonstrated the benefit of AAM for patients with OHCA due to FBAO. Further study will be required to confirm the efficacy of AAM for those patients

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension

Nanoparticles have been used as a novel drug delivery system. Drug-incorporated nanoparticles for local delivery might optimize the efficacy and minimize the side effects of drugs. The efficacy and safety of intratracheal administration of prostacyclin analog (beraprost) -incorporated nanoparticles and imatinib (a PDGF-receptor tyrosine kinase inhibitor) -incorporated nanoparticles in Sugen-hypoxia-normoxia or monocrotaline rat models of pulmonary arterial hypertension (PAH) and in human PAH-pulmonary arterial smooth muscle cells have been reported. The use of inhaled drug-incorporated nanoparticles might be a novel approach for the treatment of PAH

Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC)

<div><p>Background</p><p>Our previous study examined an effect of remote ischemic preconditioning (RIPC) or intravenous nicorandil on reduction of periprocedural myocardial injury (pMI) following percutaneous coronary intervention (PCI) in patients with stable coronary artery disease (CAD). We further investigated the effect of RIPC or nicorandil on pMI in older patients.</p><p>Methods</p><p>Patients with stable CAD who planned to undergo PCI were assigned to a 1:1:1 ratio to control, intravenous nicorandil, or upper-limb RIPC groups. This substudy analyzed patients aged >65 years (n = 282) from the principal cohort. The primary outcome was the incidence of pMI following PCI. We defined pMI as an elevated level of high-sensitive cardiac troponin T or creatine kinase myocardial band 12 or 24 hours after PCI.</p><p>Results</p><p>We found that pMI following PCI was significantly reduced in the nicorandil group compared with the control group (37.2% vs. 53.7%, multiplicity-adjusted <i>p</i> = 0.046), but not in the RIPC group compared with the control group (43.0% vs. 53.7%, multiplicity-adjusted <i>p</i> = 0.245). The adjusted odds ratios (95% confidence interval) for pMI in the RIPC and nicorandil groups versus the control group were 0.63 (0.34 to 1.16) and 0.51 (0.27 to 0.96), respectively.</p><p>Conclusion</p><p>Intravenous nicorandil significantly reduces pMI following PCI in a subgroup of older patients with stable CAD. Phase 3 trials are required to validate our results.</p><p>Trial registration</p><p>UMIN Clinical Trials Registry <a target="_blank">UMIN000005607</a>.</p></div

Odds ratios for primary and secondary outcomes in patients aged >65 years.

<p>Odds ratios for primary and secondary outcomes in patients aged >65 years.</p

Flow diagram of the study.

<p>PCI, percutaneous coronary intervention; RIPC, remote ischemic preconditioning.</p

Incidence of MACCE in patients aged > 65 years.

<p>MACCE included cardiovascular or non-cardiovascular death, admission for acute coronary syndrome, any revascularization, and admission for heart failure. MACCE, major adverse cardiac or cerebrovascular events; RIPC, remote ischemic preconditioning.</p